Larimar Therapeutics Stock Target Price
LRMR Stock | USD 7.27 0.11 1.49% |
Larimar Therapeutics fundamentals help investors to digest information that contributes to Larimar Therapeutics' financial success or failures. It also enables traders to predict the movement of Larimar Stock. The fundamental analysis module provides a way to measure Larimar Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Larimar Therapeutics stock.
Larimar | Target Price |
Larimar Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Larimar Therapeutics' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Larimar Therapeutics could also be used in its relative valuation, which is a method of valuing Larimar Therapeutics by comparing valuation metrics of similar companies.Larimar Therapeutics is currently under evaluation in target price category among related companies.
Larimar Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Larimar Therapeutics from analyzing Larimar Therapeutics' financial statements. These drivers represent accounts that assess Larimar Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Larimar Therapeutics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 563.4K | 254.4M | 185.2M | 106.4M | 199.8M | 209.7M | |
Enterprise Value | (348.6K) | 192.8M | 121.1M | 85.0M | 178.5M | 187.5M |
Larimar Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Larimar Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Larimar Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Larimar Fundamentals
Return On Equity | -0.27 | ||||
Return On Asset | -0.17 | ||||
Current Valuation | 248.91 M | ||||
Shares Outstanding | 63.8 M | ||||
Shares Owned By Insiders | 1.45 % | ||||
Shares Owned By Institutions | 98.55 % | ||||
Number Of Shares Shorted | 3.9 M | ||||
Price To Book | 5.43 X | ||||
EBITDA | (41.45 M) | ||||
Net Income | (36.95 M) | ||||
Cash And Equivalents | 54.92 M | ||||
Cash Per Share | 3.10 X | ||||
Total Debt | 5.55 M | ||||
Debt To Equity | 0.11 % | ||||
Current Ratio | 7.35 X | ||||
Book Value Per Share | 3.62 X | ||||
Cash Flow From Operations | (33.46 M) | ||||
Short Ratio | 11.30 X | ||||
Earnings Per Share | (0.96) X | ||||
Target Price | 22.4 | ||||
Number Of Employees | 42 | ||||
Beta | 0.78 | ||||
Market Capitalization | 470.86 M | ||||
Total Asset | 95.94 M | ||||
Retained Earnings | (188.55 M) | ||||
Working Capital | 80.67 M | ||||
Net Asset | 95.94 M |
About Larimar Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Larimar Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Larimar Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Larimar Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Larimar Therapeutics Piotroski F Score and Larimar Therapeutics Altman Z Score analysis. To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Larimar Stock analysis
When running Larimar Therapeutics' price analysis, check to measure Larimar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Larimar Therapeutics is operating at the current time. Most of Larimar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Larimar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Larimar Therapeutics' price. Additionally, you may evaluate how the addition of Larimar Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Larimar Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Larimar Therapeutics. If investors know Larimar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Larimar Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Return On Assets (0.17) | Return On Equity (0.27) |
The market value of Larimar Therapeutics is measured differently than its book value, which is the value of Larimar that is recorded on the company's balance sheet. Investors also form their own opinion of Larimar Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Larimar Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Larimar Therapeutics' market value can be influenced by many factors that don't directly affect Larimar Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Larimar Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Larimar Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Larimar Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.